Sverre Erik Kjeldsen

Image of Sverre Erik Kjeldsen
Norwegian version of this page
Username
Visiting address Sem Sælands vei 3 Farmasibygningen 0371 Oslo
Postal address Postboks 1068 Blindern 0316 Oslo
Other affiliations Department of Pharmacy

Publications

  • Lilja-Cyron, Alexander; Bang, Casper N.; Gerdts, Eva; Larstorp, Anne Cecilie Kjeldsen; Kjeldsen, Sverre & Julius, Stevo [Show all 9 contributors for this article] (2022). Aortic root dilatation in hypertensive patients with left ventricular hypertrophy–application of a new multivariate predictive model. The Life Study. Reviews in Cardiovascular Medicine. ISSN 1530-6550. 23:095(3), p. 1–10. doi: 10.31083/j.rcm2303095.
  • Copland, Emma; Canoy, Dexter; Nazarzadeh, Milad; Bidel, Zeinab; Ramakrishnan, Rema & Woodward, Mark [Show all 99 contributors for this article] (2021). Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis. The Lancet Oncology. ISSN 1470-2045. 22(4), p. 558–570. doi: 10.1016/S1470-2045%2821%2900033-4.
  • Bergland, Ola Undrum; Halvorsen, Lene Vernås; Søraas, Camilla Lund; Hjørnholm, Ulla; Kjær, Vibeke Norheim & Rognstad, Stine [Show all 22 contributors for this article] (2021). Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations. Hypertension. ISSN 0194-911X. 78(3), p. 617–628. doi: 10.1161/HYPERTENSIONAHA.121.17514. Full text in Research Archive
  • Kasiakogias, Alexandros; Rosei, Enrico Agabiti; Camafort, Miguel; Ehret, Georg; Faconti, Luca & Ferreira, João Pedro [Show all 19 contributors for this article] (2021). Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension. Journal of Hypertension. ISSN 0263-6352. 39(8), p. 1522–1545. doi: 10.1097/HJH.0000000000002910. Full text in Research Archive
  • Falk, Ragnhild Sørum; Mariampillai, Julian Eek; Prestgaard, Erik Edvard; Heir, Trond; Bodegard, Johan & Robsahm, Trude Eid [Show all 18 contributors for this article] (2021). The Oslo Ischaemia Study: cohort profile. BMJ Open. ISSN 2044-6055. 11(10). doi: 10.1136/bmjopen-2021-049111. Full text in Research Archive
  • Mariampillai, Julian Eek; Prestgaard, Erik Edvard; Kjeldsen, Sverre; Liestøl, Knut; Grundvold, Irene & Bodegard, Johan [Show all 9 contributors for this article] (2021). Novel insights into stroke risk beyond resting and maximal bicycle exercise systolic blood pressure. Journal of Hypertension. ISSN 0263-6352. 39(10), p. 2022–2029. doi: 10.1097/HJH.0000000000002894.
  • Parati, Gianfranco; Kjeldsen, Sverre; Coca, Antonio; Cushman, William C. & Wang, Jiguang (2021). Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis. Hypertension. ISSN 0194-911X. 77(2), p. 692–705. doi: 10.1161/HYPERTENSIONAHA.120.15781. Full text in Research Archive
  • Olsen, Eirik; Holzhauer, Björn; Julius, Stevo; Kjeldsen, Sverre; Larstorp, Anne Cecilie Kjeldsen & Mancia, Giuseppe [Show all 12 contributors for this article] (2021). Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk. Blood Pressure. ISSN 0803-7051. 30. doi: 10.1080/08037051.2020.1856642. Full text in Research Archive
  • Olsen, Eirik; Holzhauer, Björn; Julius, Stevo; Kjeldsen, Sverre; Larstorp, Anne Cecilie Kjeldsen & Mancia, Giuseppe [Show all 12 contributors for this article] (2021). Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension. Blood Pressure. ISSN 0803-7051. doi: 10.1080/08037051.2020.1855968. Full text in Research Archive
  • Kjeldsen, Sverre & Os, Ingrid (2020). Assessing hypertension therapies: randomization or confounding by indication? Nature Reviews Cardiology. ISSN 1759-5002. 17(2), p. 73–74. doi: 10.1038/s41569-019-0313-z.
  • Mahfoud, Felix; Azizi, Michel; Ewen, Sebastian; Pathak, Atul; Ukena, Christian & Blankestijn, Peter J [Show all 31 contributors for this article] (2020). Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies. European Heart Journal. ISSN 0195-668X. doi: 10.1093/eurheartj/ehaa121.
  • Burnier, Michel; Kreutz, Reinhold; Narkiewicz, Krzysztof; Kjeldsen, Sverre; Oparil, Suzanne & Mancia, Giuseppe (2020). Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: Is dosing in the evening better than in the morning? Journal of Hypertension. ISSN 0263-6352. 38(8), p. 1396–1406. doi: 10.1097/HJH.0000000000002532.
  • Mehlum, Maria Hollund; Liestøl, Knut; Kjeldsen, Sverre; Wyller, Torgeir Bruun; Julius, Stevo & Rothwell, Peter M. [Show all 10 contributors for this article] (2020). Blood pressure-lowering profiles and clinical effects of angiotensin receptor blockers versus calcium channel blockers. Hypertension. ISSN 0194-911X. 75(6), p. 1584–1592. doi: 10.1161/HYPERTENSIONAHA.119.14443.
  • Prestgaard, Erik Edvard; Mariampillai, Julian Eek; Engeseth, Kristian; Erikssen, Jan Emil; Bodegard, Johan & Liestøl, Knut [Show all 9 contributors for this article] (2020). Change in body weight and long-term risk of stroke and death in healthy men. Stroke. ISSN 0039-2499. 51(5), p. 1435–1441. doi: 10.1161/STROKEAHA.119.027233.
  • Mirza, Yusuf Ahmed; Prestgaard, Erik Edvard; Selmer, Randi Marie; Liestøl, Knut; Grundvold, Irene & Erikssen, Jan Emil [Show all 8 contributors for this article] (2020). Tiårsprediksjon av hjerte-og karsykdom hos friske norske menn basert på NORRISK-2. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 140(12), p. 1–10. doi: 10.4045/tidsskr.20.0089. Full text in Research Archive
  • Kjeldsen, Sverre; Halvorsen, Sigrun; Wyller, Torgeir Bruun; Bath, Philip M. & Sandercock, Peter (2020). Eivind Berge, MD, PhD, 1964-2020: Cardiologist Who Was Fighting Stroke. Stroke. ISSN 0039-2499. 51(5), p. 1353–1355. doi: 10.1161/STROKEAHA.120.029351.
  • Willeit, Peter; Tschiderer, Lena; Allara, Elias; Reuber, Kathrin; Seekircher, Lisa & Gao, Lu [Show all 76 contributors for this article] (2020). Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk : Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients. Circulation. ISSN 0009-7322. 142(7), p. 621–642. doi: 10.1161/CIRCULATIONAHA.120.046361.
  • Holanger, Magnus; Kjeldsen, Sverre; Jamerson, Kenneth & Julius, Stevo (2020). Smoking and overweight associated with masked uncontrolled hypertension: a Hypertension Optimal Treatment (HOT) Sub-Study. Blood Pressure. ISSN 0803-7051. p. 1–9. doi: 10.1080/08037051.2020.1787815. Full text in Research Archive
  • Okin, Peter M.; Hille, Darcy A.; Wachtell, Kristian; Kjeldsen, Sverre Erik; Julius, Stevo & Devereux, Richard B. (2020). On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy. Blood Pressure. ISSN 0803-7051. 29(5), p. 319–326. doi: 10.1080/08037051.2020.1782171. Full text in Research Archive
  • Kjeldsen, Sverre; von Lueder, Thomas Gero; Smiseth, Otto A.; Wachtell, Kristian; Mistry, Nisha & Westheim, Arne [Show all 12 contributors for this article] (2019). Medical Therapies for Heart Failure With Preserved Ejection Fraction. Hypertension. ISSN 0194-911X. doi: 10.1161/HYPERTENSIONAHA.119.14057. Full text in Research Archive
  • Mariampillai, Julian Eek; Liestøl, Knut; Kjeldsen, Sverre; Prestgaard, Erik Edvard; Engeseth, Kristian & Bodegard, Johan [Show all 11 contributors for this article] (2019). Exercise Systolic Blood Pressure at Moderate Workload Is Linearly Associated With Coronary Disease Risk in Healthy Men. Hypertension Research. ISSN 0916-9636. 75(1), p. 44–50. doi: 10.1161/HYPERTENSIONAHA.119.13528. Full text in Research Archive
  • Egan, Brent M; Kjeldsen, Sverre; Grassi, Guido; Esler, Murray D. & Mancia, Giuseppe (2019). The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? Journal of Hypertension. ISSN 0263-6352. 37(6), p. 1148–1153. doi: 10.1097/HJH.0000000000002021. Full text in Research Archive
  • Larstorp, Anne Cecilie Kjeldsen; Stokke, Ildri Maria; Kjeldsen, Sverre; Hecht Olsen, Michael; Okin, Peter M. & Devereux, Richard B [Show all 7 contributors for this article] (2019). Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE study. Blood Pressure. ISSN 0803-7051. 28(5), p. 317–326. doi: 10.1080/08037051.2019.1633905. Full text in Research Archive
  • Kjeldsen, Sverre; Aksnes, Tonje Amb; Mo, Rune & Klemsdal, Tor Ole (2019). Impact of the new ACC/AHA and ESC/ESH hypertension guidelines for Norway. European Heart Journal. ISSN 0195-668X. 40(19), p. 1485–1487. doi: 10.1093/eurheartj/ehz266.
  • Kjeldsen, Sverre; Os, Ingrid & Westheim, Anne (2019). Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial? Journal of Hypertension. ISSN 0263-6352. 37(5), p. 902–904. doi: 10.1097/HJH.0000000000002018.
  • Smiseth, Otto A.; Kjeldsen, Sverre; Andersen, Øyvind Senstad; Mistry, Nisha; Westheim, Arne & Skulstad, Helge [Show all 7 contributors for this article] (2019). Hjertesvikt med normal ejeksjonsfraksjon. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 139(6), p. 522–527. doi: 10.4045/tidsskr.18.0523.
  • Okin, Peter M.; Kjeldsen, Sverre & Devereux, Richard B (2019). Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients. Journal of Hypertension. ISSN 0263-6352. 37(3), p. 629–635. doi: 10.1097/HJH.0000000000001915.
  • Stokke, Ildri Maria; Li, Zhi Bin; Cicala, Silvana; Okin, Peter M.; Kjeldsen, Sverre & Devereux, Richard B [Show all 7 contributors for this article] (2019). Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study. Blood Pressure. ISSN 0803-7051. 28(2), p. 84–92. doi: 10.1080/08037051.2019.1569463. Full text in Research Archive
  • Mariampillai, Julian Eek; Prestgaard, Erik Edvard; Kjeldsen, Sverre; Liestøl, Knut; Engeseth, Kristian & Erikssen, Jan Emil [Show all 10 contributors for this article] (2019). SBP above 180 mmHg at moderate exercise workload increases coronary heart disease risk in healthy men during 28-year follow-up. Journal of Hypertension. ISSN 0263-6352. 37(5), p. 949–955. doi: 10.1097/HJH.0000000000001959.
  • Prestgaard, Erik Edvard; Mariampillai, Julian Eek; Engeseth, Kristian; Erikssen, Jan Emil; Bodegard, Johan & Liestøl, Knut [Show all 10 contributors for this article] (2018). Change in Cardiorespiratory Fitness and Risk of Stroke and Death. Stroke. ISSN 0039-2499. 50, p. 155–161. doi: 10.1161/STROKEAHA.118.021798.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2018). Take a blood pressure pill or benefit from renal denervation? European Heart Journal. ISSN 0195-668X. 39(33), p. 3010–3012. doi: 10.1093/eurheartj/ehy440.
  • Williams, Bryan; Mancia, Giuseppe; Spiering, Wilko; Agabiti Rosei, Enrico; Azizi, Michel & Burnier, Michel [Show all 28 contributors for this article] (2018). 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). Blood Pressure. ISSN 0803-7051. 27(6), p. 314–340. doi: 10.1080/08037051.2018.1527177.
  • Hjørnholm, Ulla; Aamodt, Josephine Jeanette Mikaela; Larstorp, Anne Cecilie Kjeldsen; Fadl Elmula, Fadl Elmula M.; Høieggen, Aud & Andersen, Marit Helen [Show all 7 contributors for this article] (2018). Directly Observed Therapy in Hypertension (DOT-HTN). In Burnier, Michel (Eds.), Drug Adherence in Hypertension and Cardiovascular Protection . Springer Nature. ISSN 978-3-319-76592-1. p. 57–85. doi: 10.1007/978-3-319-76593-8_6.
  • Mehlum, Maria Hollund; Liestøl, Knut; Kjeldsen, Sverre; Julius, Stevo; Hua, Tsushung A. & Rothwell, Peter M. [Show all 10 contributors for this article] (2018). Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. European Heart Journal. ISSN 0195-668X. 39(24), p. 2243–2251. doi: 10.1093/eurheartj/ehx760.
  • Engeseth, Kristian; Prestgaard, Erik Edvard; Mariampillai, Julian Eek; Grundvold, Irene; Liestøl, Knut & Kjeldsen, Sverre [Show all 10 contributors for this article] (2018). Physical fitness is a modifiable predictor of early cardiovascular death: A 35-year follow-up study of 2014 healthy middle-aged men. European Journal of Preventive Cardiology (EJPC). ISSN 2047-4873. 25(15), p. 1655–1663. doi: 10.1177/2047487318793459.
  • Heimark, Sondre; Mariampillai, Julian Eek; Narkiewicz, Krzysztof; Nilsson, Peter M. & Kjeldsen, Sverre (2018). Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials. High Blood Pressure & Cardiovascular Prevention. ISSN 1120-9879. 25(2), p. 151–158. doi: 10.1007/s40292-018-0258-z.
  • Okin, Peter M.; Kjeldsen, Sverre & Devereux, Richard B. (2017). The relationship of all-cause mortality to average on-treatment systolic blood pressure is significantly related to baseline systolic blood pressure: implications for interpretation of the Systolic Blood Pressure Intervention Trial study. Journal of Hypertension. ISSN 0263-6352. 36(4), p. 916–923. doi: 10.1097/HJH.0000000000001620.
  • Lüscher, Thomas F.; Kjeldsen, Sverre; Mancia, Giuseppe & Papademetriou, Vasilios (2017). From ‘essential’ hypertension to intensive blood pressure lowering: the pros and cons of lower target values. European Heart Journal. ISSN 0195-668X. 38, p. 3258–3271. doi: 10.1093/eurheartj/ehx643.
  • Kjeldsen, Sverre (2017). Hypertension and cardiovascular risk: General aspects. Pharmacological Research. ISSN 1043-6618. 129, p. 95–99. doi: 10.1016/j.phrs.2017.11.003.
  • Prestgaard, Erik Edvard; Hodnesdal, Christian; Engeseth, Kristian; Erikssen, Jan Emil; Bodegard, Johan & Liestøl, Knut [Show all 10 contributors for this article] (2017). Long-term predictors of stroke in healthy middle-aged men. International Journal of Stroke. ISSN 1747-4930. 13(3), p. 292–300. doi: 10.1177/1747493017730760.
  • Mahfoud, Felix; Schmieder, Roland E.; Azizi, Michel; Pathak, Atul; Sievert, Horst & Tsioufis, Costas [Show all 29 contributors for this article] (2017). Proceedings from the 2nd European clinical consensus conference for device-based therapies for hypertension: State of the art and considerations for the future. European Heart Journal. ISSN 0195-668X. 38(44), p. 3272–3281. doi: 10.1093/eurheartj/ehx215.
  • Jacobs, Lotte; Persu, Alexandre; Huang, Qi-Fang; Lengelé, Jean-Philippe; Thijs, Lutgarde & Hammer, Frank [Show all 21 contributors for this article] (2017). Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension. Blood Pressure. ISSN 0803-7051. 26(6), p. 321–331. doi: 10.1080/08037051.2017.1320939.
  • Okin, Peter M.; Hille, Darcy A.; Kjeldsen, Sverre Erik & Devereux, Richard B (2017). Combining ECG criteria for left ventricular hypertrophy improves risk prediction in patients with hypertension. Journal of the American Heart Association (JAHA). ISSN 2047-9980. 6(11). doi: 10.1161/JAHA.117.007564. Full text in Research Archive
  • Persu, Alexandre; Gordin, Daniel; Jacobs, Lotte; Thijs, Lutgarde; Bots, Michiel L & Spiering, Wilko [Show all 27 contributors for this article] (2017). Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-levelmeta-analysis. Journal of Hypertension. ISSN 0263-6352. 36(2), p. 221–229. doi: 10.1097/HJH.0000000000001582.
  • Mariampillai, Julian Eek; Engeseth, Kristian; Kjeldsen, Sverre Erik; Grundvold, Irene; Liestøl, Knut & Erikssen, Gunnar [Show all 9 contributors for this article] (2017). Exercise systolic blood pressure at moderate workload predicts cardiovascular disease and mortality through 35 years of follow-up in healthy, middle-aged men. Blood Pressure. ISSN 0803-7051. 26(4), p. 229–236. doi: 10.1080/08037051.2017.1291276.
  • Fadl Elmula, Fadl Elmula M.; Feng, Ying-Mei; Jacobs, Lotte; Larstorp, Anne Cecilie Kjeldsen; Kjeldsen, Sverre Erik & Persu, Alexandre [Show all 7 contributors for this article] (2017). Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis. Blood Pressure. ISSN 0803-7051. 26(4), p. 195–203. doi: 10.1080/08037051.2017.1311769.
  • Tanoue, Michael T; Kjeldsen, Sverre Erik; Devereux, Richard B & Okin, Peter M. (2017). Relationship between abnormal P-wave terminal force in lead V1 and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study. Blood Pressure. ISSN 0803-7051. 26(2), p. 94–101. doi: 10.1080/08037051.2016.1215765.
  • Palatini, Paolo; Rosei, Enrico Agabiti; Casiglia, Edoardo; Chalmers, John; Ferrari, Roberto & Grassi, Guido [Show all 16 contributors for this article] (2016). Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. Journal of Hypertension. ISSN 0263-6352. 34(5), p. 813–821. doi: 10.1097/HJH.0000000000000865.
  • Mancia, G.; Cha, Gloria; Gil-Extremera, Blas; Harvey, P; Lewin, Andrew J & Villa, Giuseppe [Show all 7 contributors for this article] (2016). Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial. Journal of Human Hypertension. ISSN 0950-9240. 31(3), p. 178–188. doi: 10.1038/jhh.2016.54.
  • Aksnes, Tonje Amb; Kjeldsen, Sverre Erik; Rostrup, Morten; Holzhauer, Björn; Hua, Tsushung A. & Julius, Stevo (2016). Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial. Blood Pressure. ISSN 0803-7051. 25(4), p. 235–240. doi: 10.3109/08037051.2015.1134071.
  • Mariampillai, Julian Eek; Eskås, Per Anders; Heimark, Sondre; Kjeldsen, Sverre Erik; Narkiewicz, Krzysztof & Mancia, Giuseppe (2016). A case for less intensive blood pressure control: it matters to achieve target blood pressure early and sustained below 140/90 mmHg. Progress in cardiovascular diseases. ISSN 0033-0620. 59(3), p. 209–218. doi: 10.1016/j.pcad.2016.09.002.
  • Kjeldsen, Sverre Erik; Dzongowski, P; Li, N; Wang, L & Radlmaier, A (2016). Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study. Journal of Clinical Pharmacy and Therapeutics. ISSN 0269-4727. 41(6), p. 695–702. doi: 10.1111/jcpt.12451.
  • Engeseth, Kristian; Hodnesdal, Christian; Grundvold, Irene; Liestøl, Knut; Gjesdal, Knut & Kjeldsen, Sverre Erik [Show all 9 contributors for this article] (2016). Temporal reduction in chronotropic index predicts risk of cardiovascular death among healthy middle-aged men: A 28-year follow-up study. Journal of the American Heart Association (JAHA). ISSN 2047-9980. 5:e004555, p. 1–12. doi: 10.1161/JAHA.116.004555.
  • Kjeldsen, Sverre Erik; Stenehjem, Aud Eldrid; Os, Ingrid; Van de Borne, Philippe; Burnier, Michel & Narkiewicz, Krzysztof [Show all 9 contributors for this article] (2016). Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets. Blood Pressure. ISSN 0803-7051. 25(6), p. 333–336. doi: 10.1080/08037051.2016.1236329.
  • Kjeldsen, Sverre Erik; Cha, Gloria; Villa, Giuseppe & Mancia, Giuseppe (2016). Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses. Journal of clinical pharmacology. ISSN 0091-2700. 56(9), p. 1120–1129. doi: 10.1002/jcph.712.
  • Okin, Peter M.; Kamel, Hooman; Kjeldsen, Sverre Erik & Devereux, Richard B. (2016). Electrocardiographic left atrial abnormalities and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy. Journal of Hypertension. ISSN 0263-6352. 34(9), p. 1831–1837. doi: 10.1097/HJH.0000000000000989.
  • Berra, Elena; Azizi, Michel; Capron, Arnaud; Høieggen, Aud; Rabbia, Franco & Kjeldsen, Sverre Erik [Show all 9 contributors for this article] (2016). Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension. Hypertension. ISSN 0194-911X. 68(2), p. 297–306. doi: 10.1161/HYPERTENSIONAHA.116.07464.
  • Persu, Alexandre; Kjeldsen, Sverre Erik; Staessen, Jan A. & Azizi, Michel (2016). Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges. Current Hypertension Reports. ISSN 1522-6417. 18(1), p. 1–11. doi: 10.1007/s11906-015-0610-9.
  • Kjeldsen, Sverre Erik; Lund-Johansen, Per; Nilsson, Peter M. & Mancia, Giuseppe (2016). Unattended blood pressure measurements in the systolic blood pressure intervention trial: Implications for entry and achieved blood pressure values compared with other trials. Hypertension. ISSN 0194-911X. 67(5), p. 808–812. doi: 10.1161/HYPERTENSIONAHA.116.07257.

View all works in Cristin

  • Burnier, Michel & Kjeldsen, Sverre (2022). A 30th anniversary and a glimpse of the future. Blood Pressure. ISSN 0803-7051. 31(1), p. 1–3. doi: 10.1080/08037051.2021.2021638.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2021). Better drug adherence improves blood pressure control and lowers cardiovascular disease outcomes–from single pill combinations to monitoring of a nationwide health insurance database. Blood Pressure. ISSN 0803-7051. 30(3), p. 143–144. doi: 10.1080/08037051.2021.1917192.
  • Burnier, Michel; Kjeldsen, Sverre; Narkiewicz, Krzysztof & Oparil, Suzanne (2021). Cuff-less measurements of blood pressure: are we ready for a change? Blood Pressure. ISSN 0803-7051. 30(4), p. 205–207. doi: 10.1080/08037051.2021.1956178.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2021). Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers. Blood Pressure. ISSN 0803-7051. 30(1), p. 1–3. doi: 10.1080/08037051.2021.1862483.
  • Gjesdal, Knut & Kjeldsen, Sverre (2021). Fusk og feil i forskning og forskningsformidling. Indremedisineren. ISSN 1891-1617. p. 54–57.
  • Kjeldsen, Sverre E.; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2021). The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug. Blood Pressure. ISSN 0803-7051. doi: 10.1080/08037051.2021.1995975.
  • Kreutz, Reinhold; Kjeldsen, Sverre E. & Mancia, Giuseppe (2021). Why we do not need a single independent international hypertension clinical practice guideline. Journal of Hypertension. ISSN 0263-6352. 39(11), p. 2125–2127. doi: 10.1097/HJH.0000000000002940.
  • Narkiewicz, Krzysztof; Burnier, Michel; Kjeldsen, Sverre & Oparil, Suzanne (2021). Combining proteomics, home blood pressure telemonitoring and patient empowerment to improve cardiovascular and renal protection. Blood Pressure. ISSN 0803-7051. 30(5), p. 267–268. doi: 10.1080/08037051.2021.1975878.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2019). Systolic blood pressure control prevents cognitive decline and slows development of white matter lesions in the brain: the SPRINT MIND study outcomes. Blood Pressure. ISSN 0803-7051. 28(6), p. 356–357. doi: 10.1080/08037051.2019.1678261.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2019). The PARAGON-Heart failure trial–another disappointment for heart failure patients with hypertension and preserved ejection fraction. Blood Pressure. ISSN 0803-7051. 28(5), p. 276–278. doi: 10.1080/08037051.2019.1664717.
  • Kjeldsen, Sverre & Os, Ingrid (2019). Are people with masked hypertension adherent to their antihypertensive medication? Hypertension. ISSN 0194-911X. 74(3), p. 497–498. doi: 10.1161/HYPERTENSIONAHA.119.13350.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2019). The PARAGON Heart Failure trial–ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction. Blood Pressure. ISSN 0803-7051. 28(4), p. 215–216. doi: 10.1080/08037051.2019.1625523.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2019). Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited. Blood Pressure. ISSN 0803-7051. 28(3), p. 144–145. doi: 10.1080/08037051.2019.1614278.
  • Kjeldsen, Sverre; Atar, Dan & von Lueder, Thomas Gero (2019). Angiotensin receptor neprilysin inhibition for the treatment of hypertension: The neglected child in cardiovascular pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(2), p. 122–123. doi: 10.1093/ehjcvp/pvz005.
  • Kjeldsen, Sverre; Fadl Elmula, Fadl Elmula M. & Persu, Alexandre (2019). Future of Renal Sympathetic Denervation in the Treatment of Hypertension. Journal of the American College of Cardiology. ISSN 0735-1097. 73(13), p. 1643–1645. doi: 10.1016/j.jacc.2019.02.008.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2019). Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension? Blood Pressure. ISSN 0803-7051. 28(2), p. 75–76. doi: 10.1080/08037051.2019.1584975.
  • Burnier, Michel; Narkiewicz, Krzysztof; Kjeldsen, Sverre & Oparil, Suzanne (2019). New data on antihypertensive drugs and risk of cancer: should we worry? Blood Pressure. ISSN 0803-7051. 28(1), p. 1–3. doi: 10.1080/08037051.2019.1568182.
  • Kjeldsen, Sverre & Mancia, Giuseppe (2019). Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results. Journal of Hypertension. ISSN 0263-6352. 37(1), p. 6–8. doi: 10.1097/HJH.0000000000001874.
  • Kjeldsen, Sverre; Mariampillai, Julian Eek & Nilsson, Peter M. (2018). Optimal blood pressure target in diabetic and nondiabetic hypertensive patients. Circulation Research. ISSN 0009-7330. 123(5), p. 528–530. doi: 10.1161/CIRCRESAHA.118.312763.
  • Mehlum, Maria Hollund; Liestøl, Knut; Kjeldsen, Sverre & Berge, Eivind (2018). Response to letters from Torp-Pedersen and colleagues and de Courson and colleagues. European Heart Journal. ISSN 0195-668X. 39(47), p. 4221–4221. doi: 10.1093/eurheartj/ehy605.
  • Kjeldsen, Sverre; Os, Ingrid & Nilsson, Peter M. (2018). Does intensive glucose control cancel out benefits of systolic blood pressure target <120 mmHg in patients with diabetes mellitus participating in accoRD? Hypertension. ISSN 0194-911X. 72(2), p. 291–293. doi: 10.1161/HYPERTENSIONAHA.118.11455.
  • Burnier, M.; Oparil, Suzanne; Narkiewicz, Krzysztof & Kjeldsen, Sverre (2018). New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden? Blood Pressure. ISSN 0803-7051. 27(2), p. 62–65. doi: 10.1080/08037051.2018.1430504.
  • Kjeldsen, Sverre & Esler, Murray D. (2018). Take a blood pressure pill or undergo renal denervation? The Lancet. ISSN 0140-6736. doi: 10.1016/S0140-6736%2818%2931126-7.
  • Narkiewicz, Krzysztof; Kjeldsen, Sverre; Burnier, Michel & Oparil, Suzanne (2018). Challenges in oscillometric blood pressure measurement in atrial fibrillation: looking for practical solutions. Blood Pressure. ISSN 0803-7051. 27(1), p. 1–2. doi: 10.1080/08037051.2017.1407218.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2017). Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials. Blood Pressure. ISSN 0803-7051. 26(5), p. 257–258. doi: 10.1080/08037051.2017.1357110.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2017). The INTERSTROKE Study: hypertension is by far the most important modifiable risk factor for stroke. Blood Pressure. ISSN 0803-7051. 26(3), p. 131–132. doi: 10.1080/08037051.2017.1292456.
  • Burnier, Michel; Narkiewicz, Krzysztof; Kjeldsen, Sverre & Oparil, Suzanne (2017). Renal denervation in hypertension: is it the end or the beginning of a SPYRAL? Blood Pressure. ISSN 0803-7051. 26(6), p. 319–320. doi: 10.1080/08037051.2017.1386539.
  • Messerli, Franz H.; Hofstetter, Louis; Agabiti-Rosei, Enrico; Burnier, Michel; Elliott, William J. & Franklin, Stanley S. [Show all 31 contributors for this article] (2017). Reply. Journal of Hypertension. ISSN 0263-6352. 35(11), p. 2327–2328. doi: 10.1097/HJH.0000000000001526.
  • Klemsdal, Tor Ole; Gjelsvik, Bjørn E.; Elling, Inger; Johansen, Sirin; Kjeldsen, Sverre Erik & Kristensen, Øivind [Show all 11 contributors for this article] (2017). Nye retningslinjer for forebygging av hjerte- og karsykdom. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 137(16), p. 1164–1168. doi: 10.4045/tidsskr.17.0109.
  • Messerli, Franz H.; Hofstetter, Louis; Agabiti-Rosei, Enrico; Burnier, Michel; Elliott, William J. & Franklin, Stanley S. [Show all 31 contributors for this article] (2017). Expertise: No longer a sine qua non for guideline authors? Journal of Hypertension. ISSN 0263-6352. 35(8), p. 1564–1566. doi: 10.1097/HJH.0000000000001435.
  • Messerli, Franz H.; Hofstetter, Louis; Agabiti-Rosei, Enrico; Burnier, Michel; Elliott, William J. & Franklin, Stanley S. [Show all 30 contributors for this article] (2017). Expertise: no longer a sine qua non for guideline authors? Hypertension. ISSN 0194-911X. 70(2), p. 235–237. doi: 10.1161/HYPERTENSIONAHA.117.09470.
  • Burnier, Michel; Narkiewicz, Krzysztof & Kjeldsen, Sverre Erik (2017). Prevention of heart failure mortality and hospitalizations in SPRINT, EMPA-REG, ALLHAT and HYVET: are diuretics the clue? Blood Pressure. ISSN 0803-7051. 26(4), p. 193–194. doi: 10.1080/08037051.2017.1332478.
  • Kjeldsen, Sverre Erik; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2017). The INTERSALT Study and the complex relationship between salt intake and blood pressure. Blood Pressure. ISSN 0803-7051. 26(2), p. 65–66. doi: 10.1080/08037051.2016.1274957.
  • Kjeldsen, Sverre Erik; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2017). The Global Burden of Disease Study 2015 and Blood Pressure. Blood Pressure. ISSN 0803-7051. 26(1). doi: 10.1080/08037051.2016.1267557.
  • Messerli, Franz H.; Bangalore, Sripal & Kjeldsen, Sverre Erik (2017). Letter by Messerli et al Regarding Article, "the Implications of Blood Pressure Measurement Methods on Treatment Targets for Blood Pressure". Circulation. ISSN 0009-7322. 135(7), p. e45–e46. doi: 10.1161/CIRCULATIONAHA.116.025301.
  • Kjeldsen, Sverre Erik; Narkiewicz, Krzysztof & Oparil, Suzanne (2017). Blood Pressure in 2016: increased impact factor and change of editors. Blood Pressure. ISSN 0803-7051. 25(6), p. 331–332. doi: 10.1080/08037051.2016.1274957.
  • Kjeldsen, Sverre Erik; Hedner, Thomas & Narkiewicz, Krzysztof (2016). HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHg. Blood Pressure. ISSN 0803-7051. 25(3), p. 131–132. doi: 10.1080/08037051.2016.1182857.
  • Kjeldsen, Sverre Erik & Lund-Johansen, Per (2016). Tynt grunnlag for å endre mål for blodtrykksbehandling. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 136(3), p. 209–210. doi: 10.4045/tidsskr.15.1298.
  • Hedner, Thomas; Kjeldsen, Sverre Erik; Narkiewicz, Krzysztof & Oparil, Suzanne (2016). The polypill: an emerging treatment alternative for secondary prevention of cardiovascular disease. Blood Pressure. ISSN 0803-7051. 25(5), p. 276–279. doi: 10.3109/08037051.2016.1139324.
  • Kjeldsen, Sverre Erik; Oparil, Suzanne; Narkiewicz, Krzysztof & Hedner, Thomas (2016). The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg. Blood Pressure. ISSN 0803-7051. 25(1), p. 1–3. doi: 10.3109/08037051.2016.1096564.

View all works in Cristin

Published Apr. 13, 2011 2:55 PM - Last modified Oct. 2, 2020 11:57 AM